The FDA has cleared Micro Dose by EOS imaging, a low dose option now available on EOS equipment.
EOS imaging received U.S. FDA clearance for Micro Dose, an option now available on EOS equipment that lowers dose of pediatric spine follow-up imaging exams, the company announced.
Micro Dose is designed for pediatric patients with orthopedic conditions that require frequent imaging exams for continuous monitoring of disease progression and treatment, the company said. Initial results presented at RSNA 1014 showed that Micro Dose generates dosage levels equivalent to a week of naturally-occurring background radiation in pediatric patients receiving 2D and 3D follow-up examinations, the company announced.
Micro Dose is in full accordance with the As Low As Reasonably Achievable (ALARA) principle, Marie Meynadier, CEO of EOS imaging, said in a release.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.